Sunshine Biopharma Inc (SBFM)
0.0594
0.00 (0.00%)
USD |
NASDAQ |
Mar 28, 16:00
0.0844
+0.02
(+42.09%)
After-Hours: 20:00
Sunshine Biopharma Gross Profit Margin (Quarterly): 33.41% for Sept. 30, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | 33.41% |
June 30, 2023 | 35.12% |
March 31, 2023 | 37.35% |
December 31, 2022 | 37.85% |
September 30, 2022 | 50.47% |
June 30, 2022 | 50.31% |
March 31, 2022 | 51.20% |
December 31, 2021 | 28.00% |
September 30, 2021 | 61.28% |
June 30, 2021 | 64.98% |
March 31, 2021 | 53.77% |
December 31, 2020 | 62.65% |
Date | Value |
---|---|
September 30, 2020 | 63.03% |
June 30, 2020 | 65.92% |
March 31, 2020 | 65.02% |
December 31, 2019 | 60.35% |
September 30, 2019 | 27.75% |
June 30, 2019 | 51.86% |
March 31, 2019 | 45.63% |
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 | -10.59% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
27.75%
Minimum
Sep 2019
65.92%
Maximum
Jun 2020
49.79%
Average
51.20%
Median
Mar 2022
Gross Profit Margin (Quarterly) Benchmarks
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -105.8% |
Return on Assets | -87.39% |
Return on Invested Capital | -102.8% |
Profit Margin (Quarterly) | -10.94% |
Operating Margin (Quarterly) | -13.08% |
Return on Net Operating Assets | -244.5% |